Sign Up to like & get
recommendations!
0
Published in 2020 at "Current pharmaceutical design"
DOI: 10.2174/1381612826666200813125159
Abstract: BACKGROUND Oxaliplatin (OXP), a 3rd generation platinum compound, is administered intravenously which causes severe side effects due to; impulse high concentration in the bloodstream thereby exposing healthy cells at a high ratio, non-specific delivery at…
read more here.
Keywords:
profile oxaliplatin;
hematology;
histopathology;
pharmacokinetic profile ... See more keywords